WATSON LABS TEVA FDA Approval ANDA 072407

ANDA 072407

WATSON LABS TEVA

FDA Drug Application

Application #072407

Application Sponsors

ANDA 072407WATSON LABS TEVA

Marketing Status

Discontinued001

Application Products

001TABLET;ORALEQ 600MG BASE0FENOPROFEN CALCIUMFENOPROFEN CALCIUM

FDA Submissions

ORIG1AP1988-06-13
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1989-07-11
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1989-07-12
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1989-07-11
LABELING; LabelingSUPPL5AP1989-04-21
BIOEQUIV; BioequivalenceSUPPL6AP1989-05-24
LABELING; LabelingSUPPL8AP1991-05-07
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1997-01-31
LABELING; LabelingSUPPL10AP2016-05-09STANDARD
LABELING; LabelingSUPPL11AP2016-05-11STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL6Null0
SUPPL9Null0
SUPPL10Null15
SUPPL11Null15

CDER Filings

WATSON LABS TEVA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 72407
            [companyName] => WATSON LABS TEVA
            [docInserts] => ["",""]
            [products] => [{"drugName":"FENOPROFEN CALCIUM","activeIngredients":"FENOPROFEN CALCIUM","strength":"EQ 600MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"FENOPROFEN CALCIUM","submission":"FENOPROFEN CALCIUM","actionType":"EQ 600MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.